Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

por Cebon, J
Publicado 2006

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer.

por Cebon, J. S., Bishop, J. F., Harvey, V., Mason, B., Jeal, P. N.
Publicado 1990

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

por Sigalotti, L, Coral, S, Altomonte, M, Natali, L, Gaudino, G, Cacciotti, P, Libener, R, Colizzi, F, Vianale, G, Martini, F, Tognon, M, Jungbluth, A, Cebon, J, Maraskovsky, E, Mutti, L, Maio, M
Publicado 2002

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

por Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, M C, Parakh, S, Cebon, J, Long, G V, Carlino, M S, Klein, O
Publicado 2016

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

por Halse, H., Colebatch, A. J., Petrone, P., Henderson, M. A., Mills, J. K., Snow, H., Westwood, J. A., Sandhu, S., Raleigh, J. M., Behren, A., Cebon, J., Darcy, P. K., Kershaw, M. H., McArthur, G. A., Gyorki, D. E., Neeson, P. J.
Publicado 2018

Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

por Cebon, J, Findlay, M, Hargreaves, C, Stockler, M, Thompson, P, Boyer, M, Roberts, S, Poon, A, Scott, A M, Kalff, V, Garas, G, Dowling, A, Crawford, D, Ring, J, Basser, R, Strickland, A, Macdonald, G, Green, M, Nowak, A, Dickman, B, Dhillon, H, Gebski, V
Publicado 2007